Notably, CD40+ and CD11c+ cells were further elevated in sulfasalazine-treated ERAP1+/− colitis mice than in WT counterparts, indicating an altered immune response and potential dysregulation in antigen presentation under conditions of ERAP1 haploinsufficiency. Here, ITGAX is linked to colitis.